Immunonutrition to reduce mouth sores after cancer treatment
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This trial studies whether special nutritional supplements (immunonutrients) can reduce painful mouth sores (oral mucositis) in people with nasopharyngeal cancer after chemoradiotherapy. If you qualify, you’ll be followed with visits and lab tests to see if the supplements improve comfort and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–70 years old (and able to be in the study if you’re a man, or a non-pregnant woman).
- You have non-keratinizing nasopharyngeal cancer, diagnosed and staged as stage III to IVA.
- Your overall health is fairly good (ECOG 0–1).
- Your blood, liver, kidney, and blood-clotting test results are within allowed ranges.
- You must be newly diagnosed and starting the study after planned chemoradiotherapy, with no prior radiation or anti-cancer treatments.
- You currently do not have mouth sores, are not malnourished, and can eat the required soft foods by mouth.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of a new immunotherapy (QL1706) plus standard chemoradiation for people with advanced nasopharyngeal cancer that hasn't spread to distant organs. The goal is to see if adding this drug helps control the cancer better than standard treatment alone.
This study looks at how the immune system responds to radiation therapy for nasopharyngeal cancer. It will use scans and blood tests to find markers that might predict how well treatment works.
This trial tests if special nutritional management during concurrent chemoradiotherapy can improve outcomes for people with nasopharyngeal cancer. If you are getting both chemotherapy and radiation as your main treatment, this study may help you maintain better nutrition.
This trial tests whether a taurine mouthwash can prevent or reduce the severity of painful mouth sores caused by radiation therapy for nasopharyngeal cancer. If it works, it could make treatment more tolerable and improve quality of life.
This trial tests if an inhaled medication called Sapylin can prevent or reduce severe mouth sores caused by chemoradiation, compared to a standard steroid inhalation. It is for people with advanced nasopharyngeal cancer who have not yet started treatment.
This trial tests whether a medicine called nanocrystalline megestrol acetate can help prevent loss of appetite caused by chemotherapy and radiation therapy in people with nasopharyngeal carcinoma. If you are receiving chemoradiotherapy for this type of cancer, you may be able to participate.
Hear when a new Locally Advanced Nasopharyngeal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.